S&P Pharmaterra has a wide variety of therapeutic experience. Most of our studies have been in two major therapeutic areas, Oncology & Cardiovascular. Why? Because these two areas represent the greatest opportunity for sponsors in Central & Eastern Europe. In addition to Oncology and Cardiovascular, we have a great deal of experience in other indications as well. Below is our complete experience by therapeutic area:

Oncology:

With over 70 oncology studies under our belt, there is simply no better team to assist you with accelerating your oncology clinical trial in Central & Eastern Europe than S&P Pharmaterra. From solid tumors to hematology, and from Phase I to Phase III, we've done it all. Given the very high rate of competing oncology trials in North America and Western Europe, utilize our region to meet your aggressive timelines.

Cardiovascular:

With over 50 cardiovascular studies to our credit, no one knows how to recruit patients and manage your cardiovascular study better than S&P Pharmaterra. The sites we work with are equipped with the most start of the art equipment necessary.